Effects of Xiaoyu tablet on blood lipid and liporoteins in hyperlipidemic rabbits with atherosclerosis

Chinese Medical Journal

Volumn 118, Issue 19, 2005, Pages 1651-1653

  Xie, Mei Lin ^a   Gu, Zhen Lun ^a   Zhu, Lu Jia ^a  

^a MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

Author keywords

Cholesterol; High density lipoprotein; Hyperlipidemia; Low density liporotein; Triglyceride

Indexed keywords

CHINESE DRUG; CRATAEGUS EXTRACT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SALVIA MILTIORRHIZA EXTRACT; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; XIAOYU;

ABDOMINAL AORTA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; CHINESE MEDICINE; CHOLESTEROL BLOOD LEVEL; COLORIMETRY; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG DOSE REGIMEN; DRUG MECHANISM; DRUG RESPONSE; HYPERLIPIDEMIA; LIPID BLOOD LEVEL; LIPID DIET; LIPOPROTEIN BLOOD LEVEL; MALE; NONHUMAN; RABBIT; RANDOMIZATION; REGULATORY MECHANISM; TABLET FORMULATION; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; ARTERIOSCLEROSIS; CHOLESTEROL, LDL; DRUGS, CHINESE HERBAL; HYPERLIPIDEMIAS; LIPIDS; LIPOPROTEINS; LIPOPROTEINS, LDL; MALE; RABBITS; TABLETS; TRIGLYCERIDES;

EID: 27144544518     PISSN: 03666999     EISSN: 03666999     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Bruckert E. Role of LDL in cardiovascular diseases. New data and new recommendations. Presse Med 2005;34:249-255.
2. Kockx MM, de Meyer GR, Muhring J, et al. Distribution of cell replication and apoptosis in atherosclerotic plaques of cholesterol-fed rabbits. Atherosclerosis 1996;120:115-124.
3. Rosenson RS, Otvos JD, Freedman DS. Relations of lipoprotein subclass levels and low-density lipoprotein size to progression of coronary artery disease in the pravastatin limitation of atherosclerosis in the coronary arteries (PLAC-I) trial. Am J Cardiol 2002;90:89-94.
4. Bavenholm P, de Faire U, Landou C, et al. Progression of coronary artery disease in young male post-infarction patients is linked to disturbances of carbohydrate and lipoprotein metabolism and to impaired fibrinolytic function. Eur Heart J 1998;19:402-410.
5. Wang JJ, Sun CP, Zhuang YY, et al. The abnormal character of elevated triglyceride in serum low-density lipoprotein in patients with coronary artery disease. Basic Med Sci Clin (Chin) 1998;18:201-204.
6. Austin MA, Hokanson JE, Edwards KL. Hypertriglyceridemia as a cardiovascular risk factor. Am J Cardiol 1998;81:7B.
7. Campos H, Moye LA, Glasser SP, et al. Low-density lipoprotein size, pravastatin treatment, and coronary events. JAMA 2001;286:1468-1474.
8. Li JZ, Chen ML, Wang S, et al. A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly. Chin Med J 2004;117:163-167.
9. Xie ML, Gu ZL, Chen KJ, et al. Study on the hypolipidemic effects of xiaoyu tablet in hyperlipidemic rabbits and rats. Chin Tradit Herb Drugs (Chin) 1998; 29:178-181.
10. Xie ML, Gu ZL, Chen KJ, et al. Xiaoyu tablet: A time-effect study on regulation of blood-lipid in hyperlipidemic mice. Chin J Mater Med (Chin) 1999;24:229-232.
11. Xie ML, Gu ZL, Zhou P, et al. Clinical investigation of xiaoyu tablet on treatment of patients with carotid atherosclerosis. Chin Tradit Pat Med (Chin) 1999;21: 515-518.
12. Xie ML, Gu ZL, Zhou P, et al. Effects of xiaoyu tablet on blood flow parameters and morphology of carotid artery in atherosclerotic patients. Chin J Integrated Tradit West Med (Chin) 2002;22:98-100.
13. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
14. Zhang LH, Liu BW. Separation of human serum lipoproteins by one-step ultracentrifugation. Acta Biochim Biophys (Chin) 1989;21:257-260.
15. Cadman E, Bostwick JR, Eichberg J. Determination of protein by a modified lowry procedure in the presence of some commonly used detergents. Anal Biochem 1979; 96:21-23.
16. Hogue JC, Lamarche B, Gaudet D, et al. Relationship between cholesteryl ester transfer protein and LDL heterogeneity in familial hypercholesterolemia. J Lipid Res 2004;45:1077-1083.
17. Vakkilainen J, Steiner G, Ansquer JC, et al. Relationship between low-density lipoprotein particle size, plasma lipoproteins, and progression of coronary artery disease: the diabetes atherosclerosis intervention study (DAIS). Circulation 2003;107:1733-1737.
18. Liu ML, Ylitalo K, Nuotio I, et al. Association between carotid intima-media thickness and low-density lipoprotein size and susceptibility of low-density lipoprotein to oxidation in asymptomatic members of familial combined hyperlipidemia families. Stroke 2002; 33:1255-1260.
19. Sniderman AD, Scantlebury T, Cianflone K. Hypertriglyceridemic hyperapoB: the unappreciated atherogenic dyslipoproteinemia in type 2 diabetes mellitus. Ann Intern Med 2001;135:447-459.